A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The study drug LY2393910 is being evaluated as a possible treatment for diabetes. The primary
purpose of a patient's participation in this study is to help answer the following research
question(s), and not to provide treatment for diabetes:
- The safety of LY2393910 and any side effects that might be associated with it following
2 weeks of doses
- How long it takes the body to absorb and remove LY2393910 following dosing over 2 weeks
- How daily dosing of LY2393910 affects blood levels of sugar (glucose), insulin and other
naturally occurring substances in your body
- How daily dosing of LY2393910 affects the cells that produce insulin
- Any differences in the above between LY2393910 taken as daily doses in the morning or in
the evening